Federal contract award
HT942525CE002
AWARD A RESEARCH AND DEVELOPMENT SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM PHASE II ENHANCEMENT AWARD TO COALESENZ, INC FOR PROJECT TITLED, POINT OF CARE BLOOD COAGULOPATHY DIAGNOSIS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $550.0K |
| Current contract value | $550.0K |
| Potential contract value / ceiling | $550.0K |
| Start date | Jul 28, 2025 |
| Current end date | Aug 27, 2026 |
| Potential end date | Aug 27, 2026 |
| Latest award activity | Jul 25, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 25, 2025 | 0 | $550.0K | AWARD A RESEARCH AND DEVELOPMENT SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM PHASE II ENHANCEMENT AWARD TO COALESENZ, INC FOR PROJECT TITLED, POINT OF CARE BLOOD COAGULOPATHY DIAGNOSIS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.